These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22949875)

  • 61. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats.
    Van Den Berge N; Ferreira N; Mikkelsen TW; Alstrup AKO; Tamgüney G; Karlsson P; Terkelsen AJ; Nyengaard JR; Jensen PH; Borghammer P
    Brain; 2021 Jul; 144(6):1853-1868. PubMed ID: 33880502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
    Trist BG; Hare DJ; Double KL
    Aging Cell; 2019 Dec; 18(6):e13031. PubMed ID: 31432604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Jenner P; Dexter DT; Sian J; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S82-7. PubMed ID: 1510385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
    Halliwell B
    Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The aging brain, metals and oxygen free radicals.
    Samson FE; Nelson SR
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):699-707. PubMed ID: 10875433
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxidative and nitrative protein modifications in Parkinson's disease.
    Danielson SR; Andersen JK
    Free Radic Biol Med; 2008 May; 44(10):1787-94. PubMed ID: 18395015
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
    Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
    Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
    J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The mitochondrial free radical theory of aging: a critical view.
    Sanz A; Stefanatos RK
    Curr Aging Sci; 2008 Mar; 1(1):10-21. PubMed ID: 20021368
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage?
    Di Monte DA; Chan P; Sandy MS
    Ann Neurol; 1992; 32 Suppl():S111-5. PubMed ID: 1510368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does oxidative stress participate in nerve cell death in Parkinson's disease?
    Hirsch EC
    Eur Neurol; 1993; 33 Suppl 1():52-9. PubMed ID: 8375433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vincamine alleviates brain injury by attenuating neuroinflammation and oxidative damage in a mouse model of Parkinson's disease through the NF-κB and Nrf2/HO-1 signaling pathways.
    Wang P; Chen C; Shan M
    J Biochem Mol Toxicol; 2024 May; 38(5):e23714. PubMed ID: 38629493
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
    Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
    Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An introduction to the free radical hypothesis in Parkinson's disease.
    Olanow CW
    Ann Neurol; 1992; 32 Suppl():S2-9. PubMed ID: 1510376
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
    Li DW; Liu ZQ; Chen W; Yao M; Li GR
    Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease.
    Basu S; Je G; Kim YS
    Exp Mol Med; 2015 Aug; 47(8):e179. PubMed ID: 26315598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.